an increase in their ability to discuss HIV with partners, and no change in number of sexual partners from baseline.Conclusions: These data demonstrate PrEP can be successfully delivered to a high-risk population with high program retention and medication adherence measured by urine tenofovir levels....
31 A third of patients in our study had hypertension, although only a few reported a previous diagnosis and fewer still were receiving anti-hypertensive medication. A similar high rate of untreated hypertension among HIV-positive patients has been reported from other regions of SSA.32 While we ...
Exclusion criteria included the following: patients with decompensated liver disease or HCC, or those co-infected with hepatitis C, hepatitis D, or HIV. Study treatment Patients were randomised 1:1, to receive either TDF 300 mg once daily or the fixed-dose combination of FTC 200 mg and TDF ...
Wohl, A. R. (2017). Plasma tenofovir levels to support adherence to TDF/FTC preexposure prophylaxis for HIV prevention in MSM in Los Angeles, California. Journal of Acquired Immune Deficiency Syn- drome, 76, 501-511.Landovitz, R. J., Beymer, M., Kofron, R., Amico, K. R., Psaros...
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intoler- ance to CART. Interim analysis of the PRO-STR study. J Int AIDS Soc. 2014;17(4 Suppl 3):19814.Podzamczer D, Rozas N, Domingo P, et al. ACTG-HIV symptoms changes in patients switched to RPV/...
Adult HIV-infected patients with viral load under 1.000 copies/mL while receiving a stable ART for at least the last three months and switched to RPV/FTC/TDF due to intolerance of previous regimen, were included. Analyses were performed by ITT. Presence/magnitude of symptoms (ACTG-HIV Symptom...